Monday 25 March 2019
Home      All news      Contact us      India
business-standard - 10 days ago

Cell therapy may replace need for kidney transplants

Regenerating damaged tissues using therapeutic cells may prove to be a promising new approach to treat chronic kidney disease, scientists say. Researchers from the Wake Forest Institute for Regenerative Medicine (WFIRM) in the US found that harnessing the unique properties of human amniotic fluid-derived stem cells could potentially help recover organ function in a pre-clinical model of kidney disease. Our results indicate that this type of stem cell could be used as an off the shelf universal cell source and may provide an alternative therapeutic strategy for patients suffering from this chronic and debilitating disease, said James J Yoo, a professor at WFIRM. Amniotic fluid-derived stem cells can be used as a universal cell source because they have the ability to become different cell types as well as the ability to be anti-inflammatory, making them a potential source for regeneration. Unlike pluripotent and adult stem cells, amniotic fluid-derived stem cells are not as likely to .

Latest News








Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)